Trillium Therapeutics

Acquired

Trillium Therapeutics was founded in 1996, is headquartered in Toronto, Canada, lists 51–200 employees, and has $1.0M in recorded funding across 1 round.

Headquarters
Toronto
Employees
51–200
Founded
1996
Business Model
B2B
Total Funding
$1.0M
Last Round
$1.0M Venture RoundMay 2011
Rounds
1
Type
Public
Acquired by
PfizerAug 2021

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Trillium Therapeutics was a clinical-stage immuno-oncology company developing innovative cancer therapies, including fusion proteins targeting CD47, the 'don't eat me' signal used by cancer cells to evade macrophage-mediated killing. Founded in 1996 and publicly traded on NASDAQ and TSX (ticker: TRIL), the company was headquartered in Toronto, Canada with a Cambridge, MA research presence. Pfizer acquired Trillium in 2021 for approximately $2.26 billion to gain access to its two clinical-stage anti-CD47 assets.

Summary

Trillium Therapeutics is a Biotech company based in Toronto, Canada, founded in 1996. It lists 51–200 employees. It has raised $1.0M in total across 1 round, most recently a $1.0M Venture Round in May 2011. Investors include Pfizer Ventures.

Funding & Exit History

AcquisitionAug 2021

Sign up to see all 2 events

Funding: Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Trillium Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/trillium-therapeutics"><img src="https://indexed.vc/api/badge/company/trillium-therapeutics" alt="Trillium Therapeutics on Indexed.vc" width="260" height="76" /></a>